Navigation Links
T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role
Date:4/4/2008

ma breast tumors, whereas the knockouts formed poorly-differentiated breast tumors with fewer blood vessels. When the adenocarcinoma tumors were transplanted into normal and T-cadherin-deficient mammary glands the knockouts were deficient in growing new blood vessels to the graft.

Stunting blood vessel growth restricts tumors and prolongs survivala strategy behind anti-angiogenesis cancer drugs like Avastinso these results were somewhat expected, says Dr. Ranscht. But what surprised us, she adds, was that even though our models survived longer, their tumor pathology worsened. Without T-cadherin-mediated vascularization, breast cancer cells consistently metastasized to the lungs, and this did not happen in the control mice where the tumors were highly vascularized.

The reasons for this trend are not clear: loose connections between vascular cells may make it easier for tumor cells to break off and enter the blood stream, or low blood flow and oxygen levels in the tumor environment may cause free radicals to build up, spurring further mutations and malignancy.

Either way, says Dr. Ranscht, Our work provides a cautionary example that restricting tumor angiogenesis might result in more aggressive disease in the long run. Thus, anti-angiogenic therapies should be carefully evaluated, because if growth at the primary tumor site slows but at the same time women develop more aggressive, metastatic cancers, then it is imperative to develop and add treatments that prevent this.

This study also showed for the first time in a living model that T-cadherin is essential for binding adiponectin, a hormone produced by fatty tissue that is released in inversely proportional amounts to body fat. Adiponectin has a protective effect against metabolic diseases including diabetes, hypertension, heart disease, and stroke; now for the first time it is linked in a living model with vascular function, a relationship that the Burnham team is still expl
'/>"/>

Contact: Andrea Moser
amoser@burnham.org
858-646-3146
Burnham Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Study finds pitching mound height affects throwing motion, injury risk
2. Gene dose affects tumor growth
3. Restless legs syndrome affects nearly 2 percent of US/UK children
4. Gender, coupled with diabetes, affects vascular disease development
5. Umbilical cord blood cell therapy may reduce signs and symptoms of Alzheimers disease
6. Umbilical cord blood cell therapy in an animal model of Alzheimers disease
7. Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
8. Diabetes makes it hard for blood vessels to relax
9. Weill Cornell team discovers how brains own tPA helps regulate blood flow to neurons
10. High blood pressure in older adults traced to genes effects in blood vessels
11. Eltrombopag effective for hepatitis C patients with low blood-platelet counts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a leading ... that its DigitalPersona ® Pro Enterprise software ... been deployed throughout First Bank branch locations in ... South Carolina and Virginia. First Bank, a ... Southern Pines, North Carolina , selected the ...
(Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... a natural environment whether it,s building a new shopping ... the environmental risks to plant and animal life in the ... an environmental disaster for an adjacent one, a Tel Aviv ... indigenous species migrate to neighboring habitats, says Guilad Friedemann, a ...
... levels of a natural body chemical may allow doctors to ... outcomes of critically ill patients. "Infection is a common ... find ways to improve the outcomes of sick, elderly patients ... Daren Heyland, a professor of Medicine at Queen,s, director of ...
... everything from smart phones to SUVs are starting to ... also for an often troublesome life after the consumer, ... News (C&EN), ACS, weekly newsmagazine. The cover ... on product stewardship, an increasingly popular approach to environmental ...
Cached Biology News:Raptor usurpers in neighboring habitats reshape the conventional wisdom 2Raptor usurpers in neighboring habitats reshape the conventional wisdom 3Finding could reduce antibiotic use in critically ill patients 2
(Date:12/15/2014)... & PETACH TIKVAH, Israel ... (NASDAQ: BCLI ), a leading developer of ... that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. was awarded ... Israel,s Office of the Chief Scientist (OCS).  ... in receipt of grant support from the Office of ...
(Date:12/15/2014)... NEW YORK , Dec. 15, 2014  GlassesOff ... Yuval Bar-Gil as an independent director of ... was founder of AeroScout and served as its CEO ... Decker in 2012, a $240 million transaction. Recognized as ... under Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID ...
(Date:12/15/2014)... 15, 2014  Ascendis Pharma A/S, a biotechnology ... address significant unmet medical needs, today announced positive ... pediatric study to evaluate once-weekly TransCon Growth Hormone ... This interim analysis consists of 25 patients, representing ... the study, completing all six months of treatment. ...
(Date:12/13/2014)... - MaRS and Virgin Unite Canada, the non-profit foundation of ... to support Canadian entrepreneurs tackling social and environmental challenges. Today, ... the MaRS Centre to announce the new partnership, which includes ... fund has $1 million in seed capital provided by Virgin ... Social Innovation Foundation, founded by Alison Lawton . ...
Breaking Biology Technology:BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
... N.J., March 5 Palatin Technologies, Inc. (NYSE Alternext ... submitted on January 23, 2009 has been accepted by ... as the American Stock Exchange). As reported on December ... it was not in compliance with certain continued listing ...
... carbon nanotubes only billionths of a meter thick ... could make airplane skins and other products some ... cost. , Moreover, advanced composites reinforced with ... more electrically conductive than their counterparts without nanotubes, ...
... 4 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... of medical devices worldwide announced today its selected ... year ended December 31, 2008.,The financial results reported ... monitoring business acquired from Datascope ("DPM") starting from ...
Cached Biology Technology:Palatin Technologies' Listing Compliance Plan Accepted by NYSE Alternext US 2MIT: 'Nanostitching' could strengthen airplane skins, more 2Mindray Announces 2008 Fourth Quarter and Full Year Results 2Mindray Announces 2008 Fourth Quarter and Full Year Results 3Mindray Announces 2008 Fourth Quarter and Full Year Results 4Mindray Announces 2008 Fourth Quarter and Full Year Results 5Mindray Announces 2008 Fourth Quarter and Full Year Results 6Mindray Announces 2008 Fourth Quarter and Full Year Results 7Mindray Announces 2008 Fourth Quarter and Full Year Results 8Mindray Announces 2008 Fourth Quarter and Full Year Results 9Mindray Announces 2008 Fourth Quarter and Full Year Results 10Mindray Announces 2008 Fourth Quarter and Full Year Results 11Mindray Announces 2008 Fourth Quarter and Full Year Results 12Mindray Announces 2008 Fourth Quarter and Full Year Results 13Mindray Announces 2008 Fourth Quarter and Full Year Results 14Mindray Announces 2008 Fourth Quarter and Full Year Results 15Mindray Announces 2008 Fourth Quarter and Full Year Results 16Mindray Announces 2008 Fourth Quarter and Full Year Results 17Mindray Announces 2008 Fourth Quarter and Full Year Results 18Mindray Announces 2008 Fourth Quarter and Full Year Results 19
... Cell Expansion Kit - Monolayer is a system ... as a monolayer in a serum-free environment. The ... Supplement, which has been optimized for neural stem ... (1996) Genes & Development 10 :3129). Human ...
... DNA Polymerase I from E. ... polymerase. The enzyme also contains ... The 5'?3' exonuclease activity enables ... and gaps in the DNA ...
... containing an overproducing clone of M-MLV Reverse ... the polymerization of DNA using template DNA, ... large mRNAs, >10 kb, may be synthesized. ... RNase H activity than AMV Reverse Transcriptase ...
... DNA Polymerase I catalyzes the template-directed ... a 5?3 direction. DNA Polymerase I possesses ... which lowers the error rate during DNA ... activity, which enables the enzyme to replace ...
Biology Products: